Literature DB >> 4808437

Antiparkinsonian agents and depot phenothiazine.

C P Chien, A Dimascio, J O Cole.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4808437     DOI： 10.1176/ajp.131.1.86

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  8 in total

1.  Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions.

Authors:  H A McClelland
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

2.  A comparative trial of the decanoates of flupenthixol and fluphenazine.

Authors:  M Hamilton; I R Card; G G Wallis; M R Mahmoud
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

Review 3.  Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly.

Authors:  Carlos Estevez-Fraga; Paul Zeun; Jose Luis López-Sendón Moreno
Journal:  Drugs Aging       Date:  2018-11       Impact factor: 3.923

4.  Tardive dystonia in a psychiatric hospital.

Authors:  J H Friedman; L T Kucharski; R L Wagner
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

5.  Genome-scale screens identify factors regulating tumor cell responses to natural killer cells.

Authors:  Michal Sheffer; Emily Lowry; Nicky Beelen; Minasri Borah; Suha Naffar-Abu Amara; Chris C Mader; Jennifer A Roth; Aviad Tsherniak; Samuel S Freeman; Olga Dashevsky; Sara Gandolfi; Samantha Bender; Jordan G Bryan; Cong Zhu; Li Wang; Ifrah Tariq; Govinda M Kamath; Ricardo De Matos Simoes; Eugen Dhimolea; Channing Yu; Yiguo Hu; Olli Dufva; Marios Giannakis; Vasilis Syrgkanis; Ernest Fraenkel; Todd Golub; Rizwan Romee; Satu Mustjoki; Aedin C Culhane; Lotte Wieten; Constantine S Mitsiades
Journal:  Nat Genet       Date:  2021-07-12       Impact factor: 38.330

Review 6.  Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy.

Authors:  Alessandra Tuccitto; Eriomina Shahaj; Elisabetta Vergani; Simona Ferro; Veronica Huber; Monica Rodolfo; Chiara Castelli; Licia Rivoltini; Viviana Vallacchi
Journal:  Virchows Arch       Date:  2018-10-29       Impact factor: 4.064

7.  Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.

Authors:  Peng Jiang; Shengqing Gu; Deng Pan; Jingxin Fu; Avinash Sahu; Xihao Hu; Ziyi Li; Nicole Traugh; Xia Bu; Bo Li; Jun Liu; Gordon J Freeman; Myles A Brown; Kai W Wucherpfennig; X Shirley Liu
Journal:  Nat Med       Date:  2018-08-20       Impact factor: 53.440

8.  The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes.

Authors:  Carlos E De Andrea; Sandra Hervas-Stubbs; Diego Salas-Benito; Enrique Conde; Ibon Tamayo-Uria; Uxua Mancheño; Edurne Elizalde; David Garcia-Ros; Jose M Aramendia; Juan C Muruzabal; Julia Alcaide; Francisco Guillen-Grima; Jose A Minguez; Jose Amores-Tirado; Antonio Gonzalez-Martin; Pablo Sarobe; Juan J Lasarte; Mariano Ponz-Sarvise
Journal:  Br J Cancer       Date:  2021-01-05       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.